Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior ...

A phase 3 trial evaluates a PARP inhibitor or placebo plus an androgen pathway inhibitor to treat men with advanced prostate cancer associated with genetic changes.

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...

A new machine-learning approach for prostate-specific membrane antigen (PSMA) treatment of metastatic castration-resistant prostate cancer (mCRPC) could estimate radiation dose to tumors and healthy ...

Former first lady Jill Biden opened up about her husband’s battle with prostate cancer in a new interview. She said in a ...

Ceramides-lipid molecules in cells that affect many physiological functions including cell differentiation, migration, and ...

High-end longevity clinics are springing up from Singapore to Southern California. They aim to prevent diseases.

Prostate and bladder cancers are among the most common urological malignancies worldwide. Traditional diagnostic approaches, including tissue biopsy, ...

Researchers tested opaganib in combination with standard hormone therapies in men with resistant prostate cancer. They ...

A study shows that detecting tumor DNA in blood can reveal prostate cancer treatment failure weeks earlier than PSA tests, ...